Advertisement

Topics

PharmaJet Inc. Company Profile

10:26 EDT 19th June 2018 | BioPortfolio

PharmaJet Inc., affiliated with Genesis Medical Technologies, is a needle-free drug delivery technology company. Through the use of its needle-free jet injection technology, the Company’s goal is to make a positive difference in improving global world health, helping to break the cycle of poverty and disease associated with needle-stick injury and needle re-use.
With FDA 510 (k) clearance for the delivery of liquid vaccines and medicines by either intramuscular and subcutaneous injections, PharmaJet’s unique technology was designed to be used in a variety of conditions---from difficult field conditions for mass vaccination programs to the most sophisticated health care environments.

Location

24797 Foothills Drive North
Golden
Colorado
80401
United States of America

Contact

Phone: 1 303 526 4278
Fax: 1 303 5264052
Email: Callender@pharmajet.com


News Articles [6 Associated News Articles listed on BioPortfolio]

PharmaJet, Genexine Partner for DNA Vaccines

The PharmaJet needle-free injection systems will be used in Genexine's Phase 1 and IIa human clinical studies

Global health startup PharmaJet with needle-free injectable device close to raising $5M

Golden, Colorado-based PharmaJet, which seeks to reduce needle-stick injury and waste, has developed a needle-free intradermal vaccine injector.

PharmaJet, Invectys enter Phase 2 cancer vaccine trial

David SalazarThe Phase 2 trial is for INVAC-1, which uses PharmaJet’s needle-free injection system and is an immunotherapeutic DNA vaccine meant to treat cancer, the companies said.  read m...

PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines

PharmaJet released positive interim results from the U.S. Army’s Phase I clinical trial of two hantavirus vaccines to prevent hemorrhagic fever with renal syndrome (HFRS).

PharmaJet’s needle-free injector succeeds in poliovirus vaccine administration study

A study has found that PharmaJet’s needle-free injection was superior to needle and syringe for fractional dose poliovirus vaccine campaigns.

AngelMD’s Catalyst Fund Invests in Six Startups During Alpha Conference

Investment platform takes a direct role in the success of six companies ahead of the JP Morgan Healthcare Conference. NAPA, Calif. (PRWEB) January 05, 2018 Today AngelMD announced that its Catalyst L...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Virus DNA Vaccine

This is a single-center, randomized, single-blinded study of the HTNV DNA vaccine alone, PUUV DNA vaccine alone, and mixed HTNV/PUUV DNA vaccines delivered IM by the needle-free PharmaJet ...

VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults

STUDY DESIGN: This is a Phase I, randomized clinical study to evaluate the safety, tolerability, and immunogenicity of a 3 dose vaccination regimen with the Zika virus (ZIKVwt) DNA vaccin...

A Campaign-based ID fIPV Administration Trial

The introduction of one dose of the inactivated poliovirus vaccine (IPV) into routine immunization schedules in OPV-only using countries as part of the Global Polio Eradication Initiative ...

Companies [3 Associated Companies listed on BioPortfolio]

PharmaJet Inc.

PharmaJet Inc., affiliated with Genesis Medical Technologies, is a needle-free drug delivery technology company. Through the use of its needle-free jet injection technology, the Company’s goal is to...

PharmaJet, Inc.

PharmaJet, Inc. is a privately held company located in Denver, Colorado; San Francisco, California and Baltimore, Maryland. It develops, manufactures and markets vaccine and drug delivery products bas...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Invi...

More Information about "PharmaJet Inc." on BioPortfolio

We have published hundreds of PharmaJet Inc. news stories on BioPortfolio along with dozens of PharmaJet Inc. Clinical Trials and PubMed Articles about PharmaJet Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PharmaJet Inc. Companies in our database. You can also find out about relevant PharmaJet Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record